201910.3 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | Compound heterozygote |
201910.5 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | Compound heterozygote
|
201910.7 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | Compound heterozygote with a large delet... |
201910.9 | Tunisia | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | |
201910.13 | Tunisia | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | Compound heterozygote |
201910.16 | Palestine | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Compound heterozygote |
201910.17 | Lebanon | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Compound heterozygote |
201910.18 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.19.1 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.19.2 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Sister of 201910.19.1 |
201910.20.1 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.20.2 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Brother of 201910.20.1 |
201910.23.1 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.23.2 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Sister of 201910.23.1 |
201910.23.3 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Sister of 201910.23.1 |
201910.24 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.26 | Lebanon | 1 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Compound heterozygous with a gene conver... |
201910.27 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.28.1 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | |
201910.28.2 | Lebanon | 2 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Delague et al, 2000 | Sibling of 201910.28.1 |
201910.G.4 | Tunisia | 10 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | 5 unrelated patients
|
201910.G.5 | Tunisia | 4 | | Pathogenic | Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency | Kharrat et al. 2004 | 2 unrelated patients
|